Log In
BCIQ
Print this Print this
 

R7277 (formerly T-5224)

  Manage Alerts
Collapse Summary General Information
Company Toyama Chemical Co. Ltd.
DescriptionTranscription factor activator protein-1 (AP-1) inhibitor
Molecular Target Activator protein-1 (AP-1) (JUN)
Mechanism of ActionActivator protein-1 (AP-1) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation
PartnerRoche

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today